Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 2
2012 1
2013 3
2014 3
2015 1
2016 2
2017 2
2018 3
2019 4
2020 4
2021 4
2022 5
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Hypereosinophilic syndrome and mepolizumab.
Verzegnassi F. Verzegnassi F. N Engl J Med. 2008 Jun 26;358(26):2838; author reply 2839-40. N Engl J Med. 2008. PMID: 18584819 No abstract available.
Rituximab Unveils Hypogammaglobulinemia and Immunodeficiency in Children with Autoimmune Cytopenia.
Ottaviano G, Marinoni M, Graziani S, Sibson K, Barzaghi F, Bertolini P, Chini L, Corti P, Cancrini C, D'Alba I, Gabelli M, Gallo V, Giancotta C, Giordano P, Lassandro G, Martire B, Angarano R, Mastrodicasa E, Bava C, Miano M, Naviglio S, Verzegnassi F, Saracco P, Trizzino A, Biondi A, Pignata C, Moschese V. Ottaviano G, et al. Among authors: verzegnassi f. J Allergy Clin Immunol Pract. 2020 Jan;8(1):273-282. doi: 10.1016/j.jaip.2019.07.032. Epub 2019 Aug 2. J Allergy Clin Immunol Pract. 2020. PMID: 31377437
Late-onset and long-lasting autoimmune neutropenia: an analysis from the Italian Neutropenia Registry.
Fioredda F, Rotulo GA, Farruggia P, Dagliano F, Pillon M, Trizzino A, Notarangelo L, Luti L, Lanza T, Terranova P, Lanciotti M, Ceccherini I, Grossi A, Porretti L, Verzegnassi F, Mastrodicasa E, Barone A, Russo G, Bonanomi S, Boscarol G, Finocchi A, Veltroni M, Ramenghi U, Onofrillo D, Martire B, Ghilardi R, Giordano P, Ladogana S, Marra N, Zanardi S, Beier F, Miano M, Dufour C. Fioredda F, et al. Among authors: verzegnassi f. Blood Adv. 2020 Nov 24;4(22):5644-5649. doi: 10.1182/bloodadvances.2020002793. Blood Adv. 2020. PMID: 33206964 Free PMC article.
Idiopathic neutropenia of infancy: Data from the Italian Neutropenia Registry.
Farruggia P, Fioredda F, Puccio G, Onofrillo D, Russo G, Barone A, Bonanomi S, Boscarol G, Finocchi A, Ghilardi R, Giordano P, Ladogana S, Lassandro G, Luti L, Lanza T, Mandaglio R, Marra N, Martire B, Mastrodicasa E, Motta M, Notarangelo LD, Pillon M, Porretti L, Serafinelli J, Trizzino A, Tucci F, Veltroni M, Verzegnassi F, Ramenghi U, Dufour C. Farruggia P, et al. Among authors: verzegnassi f. Am J Hematol. 2019 Feb;94(2):216-222. doi: 10.1002/ajh.25353. Epub 2018 Dec 18. Am J Hematol. 2019. PMID: 30456824 Free article.
Diagnosis and management of neutropenia in children: The approach of the Study Group on Neutropenia and Marrow Failure Syndromes of the Pediatric Italian Hemato-Oncology Association (Associazione Italiana Emato-Oncologia Pediatrica - AIEOP).
Fioredda F, Onofrillo D, Farruggia P, Barone A, Veltroni M, Notarangelo LD, Menna G, Russo G, Martire B, Finocchi A, Verzegnassi F, Bonanomi S, Ramenghi U, Pillon M, Dufour C. Fioredda F, et al. Among authors: verzegnassi f. Pediatr Blood Cancer. 2022 Jun;69(6):e29599. doi: 10.1002/pbc.29599. Epub 2022 Mar 6. Pediatr Blood Cancer. 2022. PMID: 35253359
Brentuximab vedotin in the treatment of paediatric patients with relapsed or refractory Hodgkin's lymphoma: Results of a real-life study.
Massano D, Carraro E, Mussolin L, Buffardi S, Barat V, Zama D, Muggeo P, Vendemini F, Sau A, Moleti ML, Verzegnassi F, D'Amico S, Casini T, Garaventa A, Schiavello E, Cellini M, Vinti L, Farruggia P, Perruccio K, Cesaro S, De Santis R, Marinoni M, D'Alba I, Mura RM, Burnelli R, Mascarin M, Pillon M. Massano D, et al. Among authors: verzegnassi f. Pediatr Blood Cancer. 2022 Oct;69(10):e29801. doi: 10.1002/pbc.29801. Epub 2022 Jun 2. Pediatr Blood Cancer. 2022. PMID: 35656841
Exenatide in type 2 diabetes.
Verzegnassi F, Chinello M. Verzegnassi F, et al. Lancet. 2010 Sep 25;376(9746):1052-3; author reply 1053. doi: 10.1016/S0140-6736(10)61485-7. Lancet. 2010. PMID: 20870094 No abstract available.
30 results